Ferrostatin-1 (Fer-1): Precision Inhibition of Ferroptosis i
2026-04-29
Explore Ferrostatin-1 (Fer-1) as a selective ferroptosis inhibitor and its pivotal role in advanced disease modeling, with a focus on mechanistic nuances and translational assay design. This article offers unique insights into reference-driven protocol refinement and practical considerations for cancer biology and neurodegenerative models.
Affinity-Purified Goat Anti-Rabbit IgG (H+L) for Signal Ampl
2026-04-28
Unlock high-sensitivity detection in immunoassays with the Affinity-Purified Goat Anti-Rabbit IgG (H+L), Horseradish Peroxidase Conjugated Secondary Antibody from APExBIO. This reagent excels in workflow flexibility, enabling robust signal amplification for Western blot, ELISA, and IHC, particularly in advanced apoptosis and pyroptosis research.
Technical Guide: Angiotensin I/II (1-5) for RAS Research Wor
2026-04-28
Angiotensin I/II (1-5) is a defined Asp-Arg-Val-Tyr-Ile peptide fragment used to model blood pressure regulation and aldosterone signaling in renin-angiotensin system (RAS) research. It is intended strictly for cardiovascular and renal studies, with specific solubility and storage requirements. Application outside these domains is not supported by current product data.
EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1
2026-04-27
EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide reagent for efficient amide bond formation in peptide synthesis and bioconjugation workflows. It is strictly intended for in vitro applications and is not recommended for in vivo or clinical use due to the absence of supporting data.
Fluorescein TSA Fluorescence System Kit: Unlocking Ultra-Sen
2026-04-27
The Fluorescein TSA Fluorescence System Kit empowers researchers to visualize low-abundance proteins and nucleic acids with unmatched sensitivity across IHC, ICC, and ISH applications. Its robust tyramide signal amplification chemistry provides enhanced signal localization, streamlining advanced workflows in inflammation and gene expression research.
Cell Counting Kit-8 (CCK-8): Precision, Power, and Translati
2026-04-26
Explore how the Cell Counting Kit-8 (CCK-8) transforms cell viability and proliferation assessment, bridging mechanistic insight with strategic guidance. Integrating evidence from cutting-edge lung regeneration research and benchmarking against legacy methods, this article provides actionable advice for translational researchers seeking robust, reproducible, and clinically meaningful results.
iRhom2 Controls Olfactory Receptor Dynamics and OSN Adaptati
2026-04-25
This study reveals iRhom2 as a selective regulator in mouse olfactory sensory neurons, influencing odorant receptor gene expression and activity-dependent adaptation. Novel transcriptomic and functional analyses illuminate a feedback loop where odor exposure modulates iRhom2 expression, reshaping our understanding of olfactory signaling plasticity.
Meta-Analysis of Azilsartan Medoxomil in Hypertension Contro
2026-04-24
This systematic review and meta-analysis rigorously evaluates the efficacy and safety of azilsartan medoxomil (TAK 491) for blood pressure reduction in patients with essential hypertension, including those with diabetes. The findings clarify its superior antihypertensive effects and comparable tolerability to control therapies, providing robust guidance for cardiovascular disease research and clinical translation.
Methyl-β-cyclodextrin: Technical Guidance for Membrane Studi
2026-04-24
Methyl-β-cyclodextrin is designed for efficient extraction of cholesterol and other lipids from cell membranes, enabling precise modulation of membrane fluidity and the study of lipid raft organization. This reagent is intended for laboratory-based research workflows in membrane biology and should not be used for diagnostic or clinical purposes.
PARP7 Inhibition Enhances IFN-I Signaling and EAE Remission
2026-04-23
This study uncovers a novel mechanism by which PARP7 suppresses type I interferon signaling through ADP-ribosylation and autophagic degradation of STAT1/STAT2. Inhibiting PARP7 stabilizes these transcription factors and alleviates experimental autoimmune encephalomyelitis in mice, suggesting new therapeutic avenues for multiple sclerosis and related autoimmune research.
Diastolic Pressure, Heart Rate, and NE Dose: New Indices for
2026-04-23
Goury et al. introduce VNERi, a novel index integrating diastolic arterial pressure, heart rate, and norepinephrine dose, which outperforms traditional hemodynamic markers in predicting outcomes in early septic shock. Their analysis demonstrates VNERi’s superior prognostic value for in-hospital mortality, vasopressor-free days, and renal replacement therapy-free days, providing a physiologically grounded tool for bedside decision-making.
MLKL Polymerization Drives Lysosomal Permeabilization in Nec
2026-04-22
This study uncovers how polymerized MLKL triggers lysosomal membrane permeabilization (LMP), leading to the release of cathepsin B and subsequent necroptotic cell death. The findings clarify a key mechanistic step in necroptosis, with implications for research on regulated cell death, inflammation, and lysosome biology.
Bradford Protein Assay Kit: Practical Guide for Rapid Quanti
2026-04-22
The Bradford Protein Assay Kit provides a rapid, sensitive approach for quantifying protein concentrations in research samples. It is well-suited for workflows requiring high throughput and minimal sample consumption. This kit should not be used for samples with interfering substances that disrupt dye binding or for quantification outside its validated range.
Dabigatran Etexilate: Innovations in Oral Anticoagulation Th
2026-04-21
This article examines the pivotal work on dabigatran etexilate, the first oral direct thrombin inhibitor approved for the prevention of stroke and venous thromboembolism. The study highlights its predictable pharmacokinetics, clinical efficacy, and potential to address the key limitations of traditional anticoagulants, shaping future anticoagulant management.
Macrophage EV-miR-660 Drives Breast Cancer Metastasis via KL
2026-04-21
This study uncovers how tumor-associated macrophage-derived extracellular vesicles (EVs) deliver microRNA-660 to breast cancer cells, promoting metastasis by targeting KLHL21 and activating the NF-κB p65 pathway. The findings highlight a mechanistic link between the tumor microenvironment and metastatic progression, offering new avenues for targeted intervention.
467 records 21/32 page Previous Next First page 上5页 2122232425 下5页 Last page